Biopharmaceutical Products and Therapies
LYMPHOMA TREATMENT AT A CROSSROADS
The shift from CAR T Cells to T-Cell engagers
Two Distinct Technologies The distinction between CAR T and TCEs begins at the molecular level CAR T therapy is a form
Clinically Validated Probiotics
Advantages, challenges, and the road ahead
The most commonly confused idea in the probiotics industry right now is that market growth equals category maturity
Advances in Biotherapeutics
Transforming drug discovery and development
According to the US Food and Drug Administration FDA biotherapeutics also known as biologicals or biopharmaceuticals
Predicting Unbound Drug Bioavailability in The Brain
Application of machine learning
In the last fifteen years unbound brain bioavailability has become a major driver of central nervous system CNS drug discovery
Antibody–Drug Conjugates: A Breakthrough in the Targeted Therapy Era
Grace Liu Technical Account Manager at Sino Biological US Inc walks us through antibodydrug conjugate ADC development highlighting their structure their therapeutic potential and the solutions Sino Biological offers to advance ADC development
The Rising Importance of Containment and Delivery Systems and Latest Trends in The Space
To properly comprehend the important role that containment and delivery systems play in the context of biologics and injectable therapies globally
Accelerating Cell and Gene Therapy Treatments to Patients with the Right CDMO Outsourcing Model
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Growing Complex Injectable Portfolio in the Indian Generic Industries
The Indian pharmaceutical industry was incepted as an APIbulk drug manufacturers which slowly diversified into fillfinish dosage form and witnessed an exponential growth in this sector for the last two decades
Safety De-risking Approaches for Advanced Modalities
Screening strategies for small molecules have evolved over decades to pan through thousands of molecules in silico and in highthroughput in vitro assays using the smallest possible amount of compound at minimal cost
Innovative Biotech Ecosystem in Singapore and Asia
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster
